Table 1 Comparison of socio-demographic and clinical characteristics between HC, AN and mixed group of BN and BED

Age, years M ± SD

24.69 ± 6.01

28.53 ± 6.97

31.83 ± 9.55

7. 85 (2, 111)

< 0.001 **

(0.12)

AN vs. HC = 0.069

BN/BED vs. HC < 0.001 **

AN vs. BN/BED = 0.142

Gender, n (%)

2.77 (4)

0.60 (0.16)

Female

33 (91.7%)

40

(93.0%)

34

(97.1%)

Male

3

(8.3%)

2

(4.7%)

1

(2.9%)

Non-binary

-

1

(2.3%)

-

BMI, kg/m² M ± SD

21.40 ± 2.47

16.98 ± 2.22

34.52 ± 12.62

59.23 (2, 111)

< 0.001 ** (0.52)

AN vs. HC = 0.022 *

BN/BED vs. HC < 0.001 **

AN vs. BN/BED < 0.001 **

Ethnicity, n (%)

33.08 (10)

< 0.001 ** (0.54)

White

17 (47.2%)

40

(93.0%)

26

(74.3%)

Black or African

-

-

1

(2.9%)

Asian

13 (36.1%)

2

(4.7%)

5

(14.3%)

Hispanic/Latino

-

-

1

(2.9%)

Mixed Race

1

(2.8%)

1

(2.3%)

2

(5.7%)

Other

5 (13.9%)

-

-

Years of Education, M ± SD

17.15 ± 2.28

17.51 ± 2.35

17.60 ± 2.76

0.30 (2, 95)

0.75 (0.05)

Diagnosis Duration (years, M ± SD)

-

10.00 (7.75)

8.62 (9.59)

2.03 (74)

0.16 (0.01)

Symptom Duration (years, M ± SD)

12.49 (8.27)

16.68 (11.04)

3.29 (74)

0.07 (0.05)

Comorbidity, n (%)

Obsessive Compulsive Disorder

-

5

(11.6%)

1

(2.9%)

Affective Disorder

-

17

(39.5%)

11

(31.4%)

Anxiety Disorder

-

15

(34.9%)

14

(40%)

Attention Deficit Hyperactivity Disorder

-

1

(2.3%)

4

(11.4%)

Autism Spectrum Disorder

-

4

(9.3%)

2

(5.7%)

Current Treatment, n (%)

10.97 (1)

< 0.001 **

(-0.38)

Treatment

-

29 (67.4%)

10

(29.4%)

No Treatment

-

14 (32.6%)

24

(70.6%)